Pulmonx (LUNG) Short-term Investments (2019 - 2025)

Pulmonx (LUNG) has 6 years of Short-term Investments data on file, last reported at $8.8 million in Q2 2025.

• Quarterly Short-term Investments fell 82.85% year-over-year to $8.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $8.8 million (down 82.85% YoY) and the FY2024 annual result came in at $30.6 million, down 8.87% from the prior year.
• Short-term Investments retreated to $8.8 million in Q2 2025 per LUNG's latest filing, from $14.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $51.1 million in Q2 2024 and bottomed at $8.8 million in Q2 2025.
• The 5-year median for Short-term Investments is $33.6 million (2023), against an average of $30.8 million.
• The widest annual swing landed in 2022, when Short-term Investments soared 318.17%; it then tumbled 82.85% in 2025.
• Tracing LUNG's Short-term Investments over 5 years: stood at $31.6 million in 2021, then rose by 24.84% to $39.4 million in 2022, then slipped by 14.84% to $33.6 million in 2023, then retreated by 8.87% to $30.6 million in 2024, then plunged by 71.35% to $8.8 million in 2025.
• Per Business Quant, the three latest LUNG Short-term Investments figures stand at $8.8 million (Q2 2025), $14.1 million (Q1 2025), and $30.6 million (Q4 2024).

Peer Comparison